To determine the specific and effective inhibitors to BC, six histone methyltransferase inhibitors including AMI-1, BIX-01294, chaetocin, DZNeP, GSK343, and UNC0631 were selected for cell proliferation experiment. Here, PRDM9 is linked to breast cancer.